Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-30 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-7155 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-715 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 |
filingDate |
2004-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2007-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-WO2005024027-A1 |
titleOfInvention |
Antibody medicine |
abstract |
It is an object of the present invention to provide a means for effectively using a low-cost treatment using an antibody drug comprising an extracellular region of IL-10 receptor 1 and a fusion protein of a human antibody. To provide an expression vector for gene therapy or vaccine by incorporating a gene encoding a fusion protein of an extracellular region of IL-10 receptor 1 and a constant region of human IgG1 into an expression vector. |
priorityDate |
2003-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |